ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

DCPC Board Okays Reissuance Of RFA for Chemoprevention Clinical Trials

May 20, 1988

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Facilities Survey Finrs $25 Million a Year for Five Years Needed From NCI By Year 1990

March 8, 1985

ACS Research Grants Hit $78.2 Million

July 18, 1986

Medical Advances Not Driven Entirely By Science, Author Physician Barron Lerner Tells Journalists

March 22, 2002